Prevention of viridans-group streptococcal septicemia in oncohematologic patients: A controlled comparative study on the effect of penicillin G and cotrimoxazole

Annals of Hematology

Volumn 64, Issue 6, 1992, Pages 260-265

  Guiot, H F L ^a   van der Meer, J W M ^b   van den Broek, P J ^a   Willemze, R ^a   van Furth, R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Cotrimoxazole; Infection; Leukemia; Penicillin; Prophylaxis; Streptococci

Indexed keywords

AMPHOTERICIN B; COTRIMOXAZOLE; NEOMYCIN; PENICILLIN G; PIPEMIDIC ACID; POLYMYXIN B; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ADOLESCENT; ADULT; AEROBIC BACTERIUM; ALPHA HEMOLYTIC STREPTOCOCCUS; ARTICLE; BACTEREMIA; CANCER CHEMOTHERAPY; CANCER PATIENT; CANDIDA; CAUSE OF DEATH; CLINICAL ARTICLE; DRUG COMPARISON; DRUG EFFICACY; DRUG HYPERSENSITIVITY; FUNGUS GROWTH; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION PREVENTION; INTRAVENOUS DRUG ADMINISTRATION; LEUKEMIA; PRIORITY JOURNAL; RESPIRATORY FAILURE; SEPTICEMIA; VASCULITIS;

AGRANULOCYTOSIS; ANTINEOPLASTIC AGENTS; BACTEREMIA; COMPARATIVE STUDY; DRUG HYPERSENSITIVITY; DRUG INTERACTIONS; DRUG RESISTANCE, MICROBIAL; HUMAN; LENGTH OF STAY; LEUKEMIA; PENICILLIN G; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS; TIME FACTORS; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0026766038     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/BF01695467     Document Type: Article

References (34)

1. Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemia
2. Fever and infection in leukemic patients. A study of 464 consecutive patients
3. Mucositis and α-streptococcal sepsis in bone marrow transplant recipients
4. Streptococcus mitis sepsis in bone marrow transplant patients receiving oral antimicrobial prophylaxis
5. Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia
6. Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukemia
7. Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin
8. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients
9. Meningitis caused by multiple antibiotic-resistant viridans streptococci
10. α-hemolytic streptococcal septicemia with severe complications during neutropenia in childhood cancer
11. Partial antibiotic decontamination
12. Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study
13. Selective antimicrobial modulation of the intestinal microbial flora for infection prevention in patients with hematologic malignancies. Evaluation of clinical efficacy and the value of surveillance cultures
14. The association between streptococcal infection and interstitial pneumonitis in chemotherapy and BMT
15. Infection prevention by modulation of the host flora
16. Respiratory failure elicited by streptococcal septicemia in patients treated with cytosine arabinoside, and its prevention by penicillin
17. Streptococcal sepsis in bone marrow transplant patients
18. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases
19. Risk factors for streptococcal septicaemia after marrow transplantation
20. Options and limitations of long-term oral ciprofloxacin as antibacterial prophylaxis in allogeneic bone marrow transplant recipients
21. α haemolytic streptococci: clinical significance in the cancer patient
22. Decreased incidence of viridans streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acyclovir
23. Prevention of bacteremia caused by α-hemolytic streptococci by roxithromycin (RU-28 965) in granulocytopenic patients receiving ciprofloxacin
24. α-streptococcal shock in bone marrow transplantation patients
25. Streptococcal septicaemia following autologous bone marrow transplantation in children with high-dose chemotherapy
26. Antimicrobial susceptibilities of streptococcus species that cause septicemia in neutropenic patients
27. Drug-induced skin reactions in patients with acute non-lymphocytic leukaemia
28. The clinical spectrum of infections with viridans streptococci in bone marrow transplant patients
29. Septicemia in pediatric oncology patients: the significance of viridans streptococcal infections
30. Incidence of trimethoprim-sulfametho-xazole-resistant enterobacteriaceae among transplant recipients
31. Intermediate and high-dose Ara-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed and acute leukaemia and lymphoblasdtic non-Hodgkin's lymphoma
32. Intermediate and high-dose Ara-C and m-AMSA for remission induction and consolidation treatment of patients with acute myeloid leukemia: an EORTC Leukemia Cooperative Group phase-II study
33. Short-term intensive treatment (V.A.A.P.) of adult acute lymphoblastic leukemia and lymphoblastic lymphoma
34. Allogeneic versus autologous BMT versus intensive consolidation in acute myelogenous leukemia in first remission. An EORTC/Gimema phase-III trial (LAM 8A)